Jin Medical International (NASDAQ:ZJYL – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.01) earnings per share (EPS) for the quarter, reports. The business had revenue of $4.46 million during the quarter.
Jin Medical International Stock Up 6.2%
NASDAQ:ZJYL traded up $0.12 during trading hours on Wednesday, hitting $2.06. 8,640,987 shares of the company were exchanged, compared to its average volume of 236,914. Jin Medical International has a 52-week low of $1.64 and a 52-week high of $17.18. The company’s 50 day moving average price is $2.21 and its 200-day moving average price is $2.38.
Analyst Ratings Changes
Separately, Weiss Ratings lowered shares of Jin Medical International from a “sell (d+)” rating to a “sell (d)” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
About Jin Medical International
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Further Reading
- Five stocks we like better than Jin Medical International
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.
